[These drugs are the main cause of Suicide]
http://www.transwor
Health and Wellness News
Reported suicides - more than 80 percent got psychiatric
drugs, well over 50 percent got antidepressants
Stockholm, Sweden 10-07-2007 02:07 GMT (TransWorldNews)
Health care providers in Sweden are per a new law required to report all
suicides committed in health care and up to four weeks after last health
care visit. The reports are sent to the National Board of Health and
Welfare for investigation.
367 suicides were reported per this law for 2006.
Data gotten via FOIA requests show: More than 80 percent of persons
committing suicide were "treated" with psychiatric drugs; in well over 50
percent of the cases the persons got antidepressants, in more than 60
neuroleptics or antidepressants.
This information has been concealed by senior (psychiatric) officials at
the National Board of Health and Welfare. It was contrary to the best
interests of Big Pharma and biological psychiatrists. It blew the myths of
antidepressants and neuroleptics as suicide protecting drugs to pieces. It
would also have hurt the career of many medical journalists to take up this
subject; journalists who for years have made their living by writing
marketing articles about new antidepressant drugs. So nothing has been
written about this in major media in Sweden.
Senior officials at the National Board of Health and Welfare have relied on
evaluations from well-known Swedish SSRI proponents, (like psychiatrists G.
Isaksson, A.L. von Knorring) who for the last decade have touted the new
antidepressants as "life saving". A senior official said that "evidence
based treatment of the underlying psychiatric disorder can reduce the risk
for suicide", referring to the "protective effect" that he believed
antidepressant drugs had. The data about the large percentage of persons
committing suicide, "treated" with psychiatric drugs, were brushed aside by
the official, saying the data "cannot currently be seen as a representative
source for a discussion about these questions" (!).
The agency has recently published its first analysis of cases from 2006,
reported per the new law (Suicides 2006, reported per Lex Maria; in
Swedish). Not a single word is written about the most compelling fact: Well
over 80 percent of persons killing themselves were treated with psychiatric
drugs.
Instead of using this result to save lives the result was hidden.
It was claimed: "Every investigated suicide where one can see flaws that
can be taken care of, can contribute to the prevention of further
suicides." Yet no investigation at all was done in the suicide inducing
effect of antidepressants and neuroleptics.
At regional level at the agency there are definitely officials wanting to
do a good job and get at the real facts of the scene. They are however
betrayed by top management. For example: The forms ordered to be used at
regional level when investigating suicide cases completely omit factors
about drug treatment.
A certain number of persons killing themselves can be expected to be
suffering from drug induced akathisia - an extreme inner restlessness, a
feeling of having to creep out of ones skin, a completely unbearable
condition. It is created by the psychiatric drugs, not by any "underlying
disease". Akathisia is a condition that can make a person commit violent
acts - against self or others. It is a condition officially recognized and
taken up in the warning texts for the drugs. A number of persons have been
affected by mania or hypomania - again created by the drugs; conditions
also officially recognized; conditions that can lead to suicide.
Some of the valid questions in an objective investigation would be: Is the
suicide an effect of an unbearable condition created by the drugs (like
akathisia)? Has the drug dose been increased - with a catastrophic result -
when the worsened condition in actual fact was caused by the drug (while
being blamed on the "underlying disease")? Has the patient been subject to
an abrupt discontinuation (with severe withdrawal symptoms as the result)?
Is the catastrophic result very likely caused by concomitant use of
psychiatric drugs? Has the patient been informed about the serious harmful
effects that these drugs can cause?
None of these questions are part of the form worked out by senior officials
at the National Board of Health and Welfare.
These questions would - if asked and the answers used - save lives. But
they would also threaten the profits of Big Pharma and the careers of their
hired psychiatrists. Therefore they cannot be asked.
Janne Larsson
writer - investigating psychiatry
Sweden
janne.olov.larsson@